Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe

Luis M Artigao-Rodenas1, Julio A Carbayo-Herencia, Juan A Divisón-Garrote

  • 1Community Medicine, Zone 3 Primary Health Care Centre, Albacete, Spain.

Plos One
|September 17, 2013
PubMed

Insights

This study validated a new cardiovascular disease risk function in a Spanish population, finding it effective for primary prevention. The model showed good discrimination and calibration, supporting its use in diverse populations.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The optimal risk function for cardiovascular disease (CVD) primary prevention remains debated.
  • The Framingham Study proposed a novel algorithm using cholesterol, blood pressure, diabetes, smoking, overall CVD prediction, and vascular age.
  • Validation of this new risk function in non-Anglo-Saxon populations is necessary.

Purpose of the Study:

  • To evaluate the validity of the Framingham Study's new risk function.
  • To assess its performance in a general, non-Anglo-Saxon population cohort over a 10-year period.

Main Methods:

  • A cohort of 959 individuals (aged 30-74) from Albacete, Spain, was studied in two cycles (1992-94 and 2004-06).
  • Data for the risk function were collected in the first cycle; CVD events were recorded during follow-up.
  • Discrimination was assessed using ROC curves, and model calibration was performed with Hosmer-Lemeshow tests.

Main Results:

  • Mean CVD risks were 11.3% for women and 19.7% for men, with ROC AUCs of 0.789 and 0.780, respectively (P<0.001).
  • CVD events predominantly occurred in the highest risk tertiles, demonstrating good predictive value.
  • The model showed good specificity in women (85.6%) and sensitivity in men (79.1%) for high-risk individuals, though it overestimated risk in older women and middle-aged men.

Conclusions:

  • The findings support the Framingham risk function's 'reclassification' proposal.
  • The model demonstrated adequate discrimination and calibration in this southern European general population sample.
  • This study suggests the utility of the revised Framingham risk function across diverse ethnic groups.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...